111 related articles for article (PubMed ID: 3166076)
1. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.
Padua RA; Carter G; Hughes D; Gow J; Farr C; Oscier D; McCormick F; Jacobs A
Leukemia; 1988 Aug; 2(8):503-10. PubMed ID: 3166076
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
3. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of ras gene activation in myeloid leukemic cells.
Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
Neubauer A; Greenberg P; Negrin R; Ginzton N; Liu E
Leukemia; 1994 Apr; 8(4):638-41. PubMed ID: 7512175
[TBL] [Abstract][Full Text] [Related]
6. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
[TBL] [Abstract][Full Text] [Related]
7. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Desta F; Pedersen-Bjergaard J
Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
[TBL] [Abstract][Full Text] [Related]
8. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
9. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
[TBL] [Abstract][Full Text] [Related]
11. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
[TBL] [Abstract][Full Text] [Related]
12. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
13. RAS mutations in patients following cytotoxic therapy for lymphoma.
Carter G; Hughes DC; Clark RE; McCormick F; Jacobs A; Whittaker JA; Padua RA
Oncogene; 1990 Mar; 5(3):411-6. PubMed ID: 2179819
[TBL] [Abstract][Full Text] [Related]
14. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
Misawa S; Horiike S; Kaneko H; Kashima K
Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
Chin YM; Bosco JJ; Koh CL
Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
[TBL] [Abstract][Full Text] [Related]
16. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
Needleman SW; Devine SE; Kraus MH
Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
[TBL] [Abstract][Full Text] [Related]
17. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
Toksoz D; Farr CJ; Marshall CJ
Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
[TBL] [Abstract][Full Text] [Related]
18. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.
Lyons J; Janssen JW; Bartram C; Layton M; Mufti GJ
Blood; 1988 Jun; 71(6):1707-12. PubMed ID: 3285909
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
20. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]